Vanguard Global Advisers
ARMP icon

Vanguard Global Advisers’s Armata Pharmaceuticals ARMP Stock Holding History

Vanguard Global Advisers’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.7K Hold
3,964
– – ﹤0.01% 3264
2026
Q1 		$40.6K Buy
+3,964
New +$33.4K ﹤0.01% 3105

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Vanguard Global Advisers's ARMP Position: Q2 2026 in Review

Vanguard Global Advisers held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 3,964 shares worth $25.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3264.

Vanguard Global Advisers first reported a position in ARMP in Q1 2026 and has held it in 2 quarters since. The position peaked at $40.6K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Vanguard Global Advisers held 3,964 shares of Armata Pharmaceuticals worth $25.7K as of Q2 2026.
  • Vanguard Global Advisers left its Armata Pharmaceuticals share count unchanged in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3264 holding.
  • Vanguard Global Advisers first reported a position in Armata Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Armata Pharmaceuticals position peaked at $40.6K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.